Publications Database

Buitelaar J. K. , Willemsen-Swinkels S. H. , van Engeland H. (1998)

Naltrexone in children with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

37(8), pp. 800-802

Kemner C. et al. (2002)

Open-label study of olanzapine in children with pervasive developmental disorder.

Journal of Clinical Psychopharmacology

22 pp. 455-460

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1999)

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

Journal of Autism and Developmental Disorders

29(2), pp. 167-169

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1995)

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behaviour in mentally retarded adults: double-blinded placebo-controlled studies.

Archives of General Psychiatry

52(9), pp. 766-773

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1995)

Placebo-controlled acute dosage naltrexone study in young autistic children.

Psychiatry Research

58(3), pp. 203-215

Read Abstract (New Window)

Willemsen-Swinkels S. H. , Buitelaar J. K. (2002)

The autistic spectrum: subgroups, boundaries, and treatment.

Psychiatric Clinics of North America

25(4), pp. 811-836

Read Abstract (New Window)

Willemsen-Swinkels S. H. , Buitelaar J. K. , van Engeland H. (1996)

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.

Biological Psychiatry

39(12), pp. 1023-1031

Read Abstract (New Window)